Home › Therapeutic areas › Neurology › Angelman Syndrome
Angelman Syndrome (2 companies)
Companies with an active program in Angelman Syndrome.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| IONS | Ionis Pharmaceuticals | CardiovascularHematology+5 Rare | 1 | Approved | 29 |
| RARE | Ultragenyx Pharmaceutical | CardiovascularGI/Hepatology+2 Rare | 1 | Approved | 12 |
No companies match.